Skip to main content
. 2019 Sep;8(5):1806–1816. doi: 10.21037/tcr.2019.08.31

Table 3. Correlations of ITGA7 expression with clinical characteristics.

Items ITGA7 expression P value
High Low
Age, No. (%) 0.607
   ≤60 years 82 (64.6) 45 (35.4)
   >60 years 88 (61.5) 55 (38.5)
Gender, No. (%) 0.753
   Male 135 (62.5) 81 (37.5)
   Female 35 (64.8) 19 (35.2)
Pathological grade, No. (%) 0.001
   G1 18 (42.9) 24 (57.1)
   G2 107 (63.7) 61 (36.3)
   G3 45 (75.0) 15 (25.0)
Tumor size, No. (%) 0.029
   ≤5 cm 54 (54.5) 45 (45.5)
   >5 cm 116 (67.8) 55 (32.2)
LYN, No. (%) 0.014
   No 95 (57.2) 71 (42.8)
   Yes 75 (72.1) 29 (27.9)
TNM stage, No. (%) <0.001
   I 42 (48.8) 44 (51.2)
   II 55 (64.0) 31 (36.0)
   III 73 (74.5) 25 (25.5)

Correlations were determined by Chi-square test or Wilcoxon rank sum test, P value <0.05 was considered significant. ITGA7, integrin-α7; LYN, lymph node metastasis.

HHS Vulnerability Disclosure